Severe congenital neutropenia‐associated JAGN1 mutations unleash a calpain‐dependent cell death programme in myeloid cells-Reference-Cited by-同舟云学术

Severe congenital neutropenia‐associated JAGN1 mutations unleash a calpain‐dependent cell death programme in myeloid cells

Published:2020-11-18 Issue:1 Volume:192 Page:200-211
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Khandagale Avinash¹,Holmlund Teresa¹,Entesarian Miriam²³,Nilsson Daniel³⁴,Kalwak Krzysztof⁵,Klaudel‐Dreszler Maja⁶,Carlsson Göran²,Henter Jan‐Inge²,Nordenskjöld Magnus³,Fadeel Bengt¹^ORCID

Affiliation:

1. Division of Molecular Toxicology Institute of Environmental MedicineKarolinska Institutet StockholmSweden

2. Department of Women's and Children's Health Karolinska InstitutetKarolinska University Hospital Solna StockholmSweden

3. Department of Molecular Medicine and Surgery, and Center for Molecular Medicine Karolinska InstitutetKarolinska University Hospital Solna StockholmSweden

4. Science for Life Laboratory Karolinska Institutet Stockholm Sweden

5. Department and Clinic of Pediatric Oncology, Hematology and Bone Marrow Transplantation Wroclaw Medical University WroclawPoland

6. Department of Gastroenterology, Hepatology, Nutritional Disorders, and Paediatrics Children’s Memorial Health Institute Warsaw Poland

Publisher

Wiley

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bjh.17137

Reference43 articles.

1. Congenital neutropenia in the era of genomics: classification, diagnosis, and natural history

2. Stable long-term risk of leukaemia in patients with severe congenital neutropenia maintained on G-CSF therapy